These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7972205

  • 1. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 3. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 4. Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma.
    Kogner P, Barbany G, Persson H, Söderhäll S, Ahström L, Björk O.
    Prog Clin Biol Res; 1994 Mar 25; 385():147-53. PubMed ID: 7972206
    [Abstract] [Full Text] [Related]

  • 5. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
    Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM.
    Prog Clin Biol Res; 1994 Mar 25; 385():169-75. PubMed ID: 7972209
    [Abstract] [Full Text] [Related]

  • 6. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 7. Basophil priming by neurotrophic factors. Activation through the trk receptor.
    Bürgi B, Otten UH, Ochensberger B, Rihs S, Heese K, Ehrhard PB, Ibanez CF, Dahinden CA.
    J Immunol; 1996 Dec 15; 157(12):5582-8. PubMed ID: 8955210
    [Abstract] [Full Text] [Related]

  • 8. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E, Gestblom C, Johansson I, Nånberg E, Påhlman S.
    Cell Growth Differ; 1995 Jun 15; 6(6):727-36. PubMed ID: 7669728
    [Abstract] [Full Text] [Related]

  • 9. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
    Tanaka T, Hiyama E, Sugimoto T, Sawada T, Tanabe M, Ida N.
    Cancer; 1995 Sep 15; 76(6):1086-95. PubMed ID: 8625212
    [Abstract] [Full Text] [Related]

  • 10. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 11. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J, De Vathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J.
    Cancer Res; 1991 Jan 01; 51(1):33-6. PubMed ID: 1988094
    [Abstract] [Full Text] [Related]

  • 12. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
    Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM.
    Cell Growth Differ; 1990 Sep 01; 1(9):421-8. PubMed ID: 1963076
    [Abstract] [Full Text] [Related]

  • 13. [Neuroblastoma].
    Sawada T, Komatsu H, Shirai C, Yamamoto S, Ishiwari K, Ishida H, Ohmizono Y, Matsumura T.
    Gan To Kagaku Ryoho; 1995 Jan 01; 22(1):28-36. PubMed ID: 7826075
    [Abstract] [Full Text] [Related]

  • 14. Molecular pathology of human neuroblastomas.
    Brodeur GM.
    Semin Diagn Pathol; 1994 May 01; 11(2):118-25. PubMed ID: 7809505
    [Abstract] [Full Text] [Related]

  • 15. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
    Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC.
    Prog Clin Biol Res; 1994 May 01; 385():163-8. PubMed ID: 7972208
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E, Peterson S, Maekawa K, Matsushima H.
    Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468
    [Abstract] [Full Text] [Related]

  • 17. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
    Matsunaga T, Shirasawa H, Hishiki T, Yoshida H, Kouchi K, Ohtsuka Y, Kawamura K, Etoh T, Ohnuma N.
    Clin Cancer Res; 2000 Aug 05; 6(8):3199-204. PubMed ID: 10955804
    [Abstract] [Full Text] [Related]

  • 18. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
    Christiansen H, Christiansen NM, Wagner F, Altmannsberger M, Lampert F.
    Oncogene; 1990 Mar 05; 5(3):437-40. PubMed ID: 2156211
    [Abstract] [Full Text] [Related]

  • 19. Expression of TrkC in favorable human neuroblastomas.
    Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM.
    Oncogene; 1996 Jan 04; 12(1):37-41. PubMed ID: 8552397
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
    Kim CJ, Chi JG, Thiele CJ.
    Lab Invest; 1999 Aug 04; 79(8):1007-13. PubMed ID: 10462038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.